Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The Vapor C Trial

VAPOR-C is a pragmatic, event-driven, randomised controlled trial, with a blinded 2x2 factorial design for
sevoflurane/propofol and for intravenous lidocaine/placebo administration.
The primary aims of this study will test if: (1) Intravenous propofol-TIVA (vs. inhalational anaesthesia), and/or (2) intravenous lidocaine analgesia (vs. placebo) improve disease-free survival (DFS) following major cancer surgery.

Project Information

Institution:

Peter MacCallum Cancer Centre

Specialities:

Anaesthesia

Oncology

Surgery

End date:

​

Can this be done remotely?

​

Suitability:

Senior clinician

Parts of research done:

Literature review, Research proposal, Ethics approval

Positions Available:

New sites

​

​

Current Funding:

NHMRC

​

Prospective researchers receive:

​

Website

​

Project owner

Sam McKeown

Please fill out the form below to express your interest in this research project. It is free to contact a project owner and express interest in a project. We recommend writing a detailed message regarding why you are interested in the project (e.g. what skills you can bring to the team) or what information you are seeking (e.g. detail regarding the study duration). All information you provide will be shared with the primary researcher, including your contact details. Thank you for your interest in this project.